Reducing Fluids Intakes in Neonatal Intensive Care

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07715513

Acronym

REFINI

Enrollment

Registered

2026-07-20

Start date

2024-06-01

Completion date

2025-09-30

Last updated

2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Intensive Care Unit

Keywords

Fluide intake, newborn, premature, treatment protocol, infusion

Brief summary

During stay in the neonatal intensive care unit, newborns requires various treatments administered intravenously. The hidden fluid intake associated with these infusion can lead to fluid overlad, increasing the risk of complications.This study aims to describe the variation of hidden fluid intake associated with treatment infusion, develop a new care protocol for the administration of intravenous medication in the neonatal intensive care unit, and finally standardize care practices related to the infusion of medication to improve the safety and quality of care for newborns.

Interventions

PROCEDUREhidden fluid intake

comparaison of additionnel fluids intakes before and after practical modification

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Days to No maximum

Healthy volunteers

Inclusion criteria

* newborns in neonatal intensive care * gestational age between 24 to 37 weeks of amenorrhoea * weight birth between 500g to 4500g

Exclusion criteria

* newborn without intravenous divice

Design outcomes

Primary

Measure	Time frame	Description
hidden fluid intake	At Day 0, day 1, Day 7, Day 14, Day 19.	Volume in milliliters per kilogram of hidden intakes associated with continuous and intermittent drug treatments administered daily

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026